Stroke Prevention Trial in Children With Sickle Cell Disease and Iron Overload Halted

The SWITCH trial, comparing hydroxyurea with phlebotomy to standard therapy with blood transfusions and deferasirox, was halted when the former new combination failed to offer additional benefit. Medscape Medical News (Source: Medscape Today Headlines)

Source: http://www.medworm.com/index.php?rid=3645525&cid=c_183_26_f&fid=36062&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F723291%3Fsrc%3Drss

phlebotomy certification chicago phlebotomy training bay area free phlebotomy training